Summit Financial »

Elicio Therapeutics shares owned by Summit Financial

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Summit Financial from 13F filings

Historical chart of Summit Financial investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Summit Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Summit Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $80k 10k 7.96

More positions owned by Summit Financial

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Summit Financial

Top funds holding Elicio Therapeutics

Knoll Capital Management
Vanguard Group
Balyasny Asset Management
Geode Capital Management
Marshall Wace
Susquehanna International
683 Capital Management
Northern Trust
State Street Corporation
BlackRock
UBS Group
Renaissance Technologies
CM Management
OMERS Administration Corporation
Millennium Management

View all funds holding Elicio Therapeutics